BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15476326)

  • 1. [Relationship between drug resistance and the expression of NF-kappaB induced in leukemic cells].
    Zhang XH; Su LD; Lu QH; Liang Y; Zhao XY
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 33(5):421-6. PubMed ID: 15476326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
    Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide inhibits proliferation in K562 cells by changing cell cycle and survivin expression.
    Wu X; Chen Z; Liu Z; Zhou H; You Y; Li W; Zou P
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(4):342-4, 353. PubMed ID: 15587394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide inhibits DNA methyltransferase and restores TMS1 gene expression in K562 cells.
    Li H; Wang Y; Xu W; Dong L; Guo Y; Bi K; Zhu C
    Acta Haematol; 2015; 133(1):18-25. PubMed ID: 24993472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulindac enhances arsenic trioxide-mediated apoptosis by inhibition of NF-kappaB in HCT116 colon cancer cells.
    Lee HR; Cheong HJ; Kim SJ; Lee NS; Park HS; Won JH
    Oncol Rep; 2008 Jul; 20(1):41-7. PubMed ID: 18575716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular signal-regulated kinase 8-mediated NF-κB activation increases sensitivity of human lung cancer cells to arsenic trioxide.
    Wu DD; Lau ATY; Yu FY; Cai NL; Dai LJ; Ok Kim M; Jin DY; Xu YM
    Oncotarget; 2017 Jul; 8(30):49144-49155. PubMed ID: 28467781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the mechanism involved in the As2O3-regulated decrease in MDR1 expression in leukemia cells.
    Gao F; Liu J; Dong WW; Wang W; Wang Y; Cai D; Zheng Z; Sun K
    Oncol Rep; 2014 Feb; 31(2):926-32. PubMed ID: 24337533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Arsenic trioxide induced leukemic cell apoptosis relative to NF-kappaB activation].
    Xu XP; Xu XW; Yi K; Chen L; Chen SY; Zhou F; Li QY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):764-8. PubMed ID: 16277838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arsenic trioxide combined with buthionine sulfoximine enhances apoptosis in multidrug-resistant human leukemia K562/ADM cells in vitro].
    Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):188-91. PubMed ID: 18756933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation.
    El-Sabban ME; Nasr R; Dbaibo G; Hermine O; Abboushi N; Quignon F; Ameisen JC; Bex F; de Thé H; Bazarbachi A
    Blood; 2000 Oct; 96(8):2849-55. PubMed ID: 11023521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of leukemic T-cell lines to arsenic trioxide cytotoxicity is dependent on the induction of phosphatase B220/CD45R expression at the cell surface.
    Benbijja M; Mellouk A; Bobé P
    Mol Cancer; 2014 Nov; 13():251. PubMed ID: 25410152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arsenic trioxide enhances TRAIL inducing human lung cancer cell line A549 cells apoptosis by down-regulate the expression of NF-kappaB].
    Wang JY; Zhao XQ; Wang CM; Mo BW; Jiang M; Chen F
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):834-8. PubMed ID: 23387208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of nuclear matrix proteins during arsenic trioxide induced apoptosis in leukemia K562 cells.
    Wang ZH; Yu D; Chen Y; Hao JZ
    Chin Med J (Engl); 2005 Jan; 118(2):100-4. PubMed ID: 15667793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of dexamethasone on arsenic trioxide induced apoptosis, NF-kappaB activation and gene expression in lymphoma cell line].
    Xu XW; Xu XP; Yi K; Chen L; Chen SY; Zhou F; Li QY
    Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):227-31. PubMed ID: 15949266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells.
    Tabellini G; Cappellini A; Tazzari PL; Falà F; Billi AM; Manzoli L; Cocco L; Martelli AM
    J Cell Physiol; 2005 Feb; 202(2):623-34. PubMed ID: 15316930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide represses NF-kappaB activation and increases apoptosis in ATRA-treated APL cells.
    Mathieu J; Besançon F
    Ann N Y Acad Sci; 2006 Dec; 1090():203-8. PubMed ID: 17384263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of arsenic trioxide (As2O3) combined with BSO on K562/ADM cell and its mechanisms].
    Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):438-43. PubMed ID: 18072624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins.
    Chen GQ; Zhu J; Shi XG; Ni JH; Zhong HJ; Si GY; Jin XL; Tang W; Li XS; Xong SM; Shen ZX; Sun GL; Ma J; Zhang P; Zhang TD; Gazin C; Naoe T; Chen SJ; Wang ZY; Chen Z
    Blood; 1996 Aug; 88(3):1052-61. PubMed ID: 8704214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance.
    Lehmann S; Bengtzen S; Paul A; Christensson B; Paul C
    Eur J Haematol; 2001 Jun; 66(6):357-64. PubMed ID: 11488934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide.
    Hour TC; Huang CY; Lin CC; Chen J; Guan JY; Lee JM; Pu YS
    Anticancer Drugs; 2004 Sep; 15(8):779-85. PubMed ID: 15494640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.